ERAN ELINAV;HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD.;YARON ILAN;ENZO THERAPEUTICS INC.;MAYA MARGALIT
发明人:
YARON ILAN,MAYA MARGALIT,ERAN ELINAV
申请号：
IL20188909
公开号：
IL201889A
申请日:
2009.11.02
申请国别(地区):
IL
年份:
2014
代理人:
摘要：
The present invention relates to a method for the treatment of immune-related disorders in a mammalian subject in need of such treatment. This method comprises the step of manipulating the NK T cell population in said subject by suitable means, said manipulation of the NK T cell population resulting in modulation of the Th1/Th2 balance toward anti-inflammatory cytokine producing cells. Manipulation of the NK T cell population may be performed either by depletion of said cells by a suitable means or alternatively by ex vivo education of the NK T cells, such that the educated NK T cells have the capability to modulate the Th1/Th2 balance toward anti-inflammatory cytokine producing cells. The invention further relates to pharmaceutical compositions for the treatment of immune-related disorders in a mammalian subject. These compositions comprising as an effective ingredient an ex vivo educated NK T cell. The invention further provides for an ex vivo educated NK T cell and uses thereof in the treatment of immune-related disorders.
